FUSOGENIC
DEAD

Serial Number

77227858

Owner

Viventia Biotech Inc.

Attorney

William F. Lawrence, Esq.

Filing Date

Jul 12, 2007

Add to watchlist:

No watchlists yet
View on USPTO

FUSOGENIC Trademark

Serial Number: 77227858

FUSOGENIC is a trademark filed by Viventia Biotech Inc. on July 12, 2007. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Viventia Biotech Inc. (14 trademarks)

Suite 405
Mississauga, Ontario L4W 5N5 , CA

Entity Type: 03

VIVENTIA BIOTECHNOLOGIES INC. (10 trademarks)

7895 TRANMERE DRIVE, SUITE 204
MISSISSAUGA, ONTARIO L5S 1V9 , CA

Entity Type: 03

Trademark Details

Filing Date

July 12, 2007

Registration Date

Not Registered

Goods & Services

Biopharmaceutical preparations and biotechnology preparations for medical purposes for the treatment of malignant and benign tumors; cancer; immune diseases, including autoimmune, inflammatory diseases, infectious diseases and vascular diseases; synthetic polypeptides for biopharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes, namely, monoclonal antibodies, human antibodies, immune toxins; toxin proteins, and proteins for clinical or medical laboratory use

Biotechnology preparations for commercial purposes, namely, recominant-generated antibodies and recominant fragments thereof for commercial purposes; biopharmaceutical and biotechnology products; diagnostic preparations for laboratory and medical research purposes; nucleic acids for laboratory use; biological tissue, namely, stem cells for scientific and medical research use; protein arrays for scientific and medical research; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; diagnostic preparations for scientific use, namely, monoclonal antibodies, human antibodies, immune toxins; proteins for clinical or medical laboratory use

Medical and scientific research and development services, namely, preparation and development of proteins and in vitro generated recombinant antibodies and proteins, and fragments thereof; product development services for others in the field of medical and scientific research and development; medical laboratory services, namely, preparation and screening of libraries of proteins and antibodies, libraries of cells producing antibodies and proteins, and libraries of vector coding for antibodies and proteins

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 9, 2013 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 9, 2013 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 11, 2012 GNRN
NON-FINAL ACTION E-MAILED
Oct 11, 2012 GNRT
NON-FINAL ACTION WRITTEN
Oct 11, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2012 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 14, 2012 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 17, 2012 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 17, 2012 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 17, 2012 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 12, 2012 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 10, 2011 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 10, 2011 GNSL
SUSPENSION LETTER WRITTEN
Sep 10, 2011 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 1, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 1, 2011 CRFA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 31, 2011 ASGN
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2011 TROA
PETITION TO REVIVE-GRANTED
Aug 25, 2011 PETG
TEAS PETITION TO REVIVE RECEIVED
Aug 25, 2011 PROA
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Aug 15, 2011 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 13, 2011 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 15, 2011 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 15, 2011 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 15, 2011 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 12, 2011 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 30, 2010 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 30, 2010 GNSL
SUSPENSION LETTER WRITTEN
Jun 30, 2010 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2010 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 14, 2010 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 15, 2009 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 15, 2009 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 15, 2009 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 7, 2009 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 5, 2009 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 5, 2009 GNSL
SUSPENSION LETTER WRITTEN
Jun 5, 2009 CNSL
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Dec 8, 2008 GNS2
INQUIRY TO SUSPENSION E-MAILED
Dec 8, 2008 GNSI
SUSPENSION INQUIRY WRITTEN
Dec 8, 2008 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 15, 2008 RCCK
ASSIGNED TO LIE
Nov 15, 2008 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 15, 2008 GNS3
LETTER OF SUSPENSION E-MAILED
May 15, 2008 GNSL
SUSPENSION LETTER WRITTEN
May 15, 2008 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2007 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2007 CNRT
ASSIGNED TO EXAMINER
Oct 16, 2007 DOCK
NEW APPLICATION ENTERED
Jul 17, 2007 NWAP